Cargando…

Small-Cell Lung Cancer—An Update on Targeted and Immunotherapies

Small-cell lung cancer (SCLC) is an aggressive disease with distinct biological and clinical features. The clinical course of SCLC is generally characterised by initial sensitivity to DNA-damaging therapies, followed by early relapse and broad cross resistance to second line agents. Whilst there has...

Descripción completa

Detalles Bibliográficos
Autores principales:	McNamee, Nicholas, da Silva, Ines Pires, Nagrial, Adnan, Gao, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179261/ https://www.ncbi.nlm.nih.gov/pubmed/37175833 http://dx.doi.org/10.3390/ijms24098129

Ejemplares similares

Use of durvalumab in stage III non‐small‐cell lung cancer based on eligibility for the PACIFIC study
por: Boys, Emma, et al.
Publicado: (2023)

Five‐year survival and clinical correlates among patients with advanced non‐small cell lung cancer, melanoma and renal cell carcinoma treated with immune check‐point inhibitors in Australian tertiary oncology centres
por: Brown, Lauren J, et al.
Publicado: (2022)

Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?
por: McNamee, Megan Jessica, et al.
Publicado: (2021)

Immunotherapy in non-small cell lung cancer: Update and new insights
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates
por: Suraya, Ratoe, et al.
Publicado: (2022)

Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
por: Sa, Huanlan, et al.
Publicado: (2019)

General practitioner knowledge, skills and attitudes to eating disorders
por: Doherty, S, et al.
Publicado: (2015)

Gene Transfer for Pain: A tool to cope with the intractable, or an unethical enduranceenhancing technology?
por: Camporesi, S, et al.
Publicado: (2012)

Modeling timelines for translational science in cancer; the impact of technological maturation
por: McNamee, Laura M., et al.
Publicado: (2017)

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
por: Lee, Hansol, et al.
Publicado: (2021)

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype
por: O’Neill, Sadhbh, et al.
Publicado: (2019)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

Translational Science by Public Biotechnology Companies in the IPO“Class of 2000”: The Impact of Technological Maturity
por: McNamee, Laura, et al.
Publicado: (2013)

Introduction
por: McNamee, Terence, et al.
Publicado: (2020)

Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices
por: Roque, Katia, et al.
Publicado: (2023)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shang, Shijie, et al.
Publicado: (2021)

Sex difference in response to non-small cell lung cancer immunotherapy: an updated meta-analysis
por: Liang, Jiali, et al.
Publicado: (2022)

Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges
por: Xing, Shuqin, et al.
Publicado: (2022)

Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Performance enhancement, elite athletes and anti doping governance: comparing human guinea pigs in pharmaceutical research and professional sports
por: Camporesi, Silvia, et al.
Publicado: (2014)

Consent, ethics and genetic biobanks: the case of the Athlome project
por: Thompson, Rachel, et al.
Publicado: (2017)

Interaction of different lipoprotein types with cholesterol at the air/water interface
por: Ninomiya, Ryota, et al.
Publicado: (2020)

Immunotherapy in Small Cell Lung Cancer
por: Esposito, Giovanna, et al.
Publicado: (2020)

Numerical methods for roots of polynomials
por: McNamee, J M, et al.
Publicado: (2013)

Ectopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur?
por: McNamee, Eóin N., et al.
Publicado: (2016)

Ethics, Nanobiosensors and Elite Sport: The Need for a New Governance Framework
por: Evans, Robert, et al.
Publicado: (2016)

Derivation and application of a composite annoyance reaction construct based on multiple wind turbine features
por: Michaud, David S., et al.
Publicado: (2018)

The association between self-reported and objective measures of health and aggregate annoyance scores toward wind turbine installations
por: Michaud, David S., et al.
Publicado: (2018)

Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers
por: Jakate, Abhijeet, et al.
Publicado: (2019)

Barriers and Facilitators for Implementation of Individualized Fire Safety (IFS) in Sweden
por: Gustavsson, Johanna, et al.
Publicado: (2021)

Medical abortion in primary care
por: Bateson, Deborah, et al.
Publicado: (2021)

Clinical associate students’ perceptions of factors that influence their developing professional identity: a qualitative study
por: Mgobozi, Aviwe, et al.
Publicado: (2023)

Exploring medication safety through a social determinants of health and health literacy lens
por: McNamee, H, et al.
Publicado: (2023)

An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer
por: McNamee, Niamh, et al.
Publicado: (2023)

Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non–Small Cell Lung Cancer
por: Waxman, Elizabeth S., et al.
Publicado: (2016)

The TYPO3 Guidebook: Understand and Use TYPO3 CMS
por: Brand, Felicity, et al.
Publicado: (2021)

Protocol for inspecting blood cell dynamics with a custom ektacytometer-rheometer apparatus
por: Fitzpatrick, Tom, et al.
Publicado: (2022)

Immunotherapy for Non-Small Cell Lung Cancer
por: Yoon, Sung Ho
Publicado: (2014)

Immunotherapy in extensive small cell lung cancer
por: Verma, Vaibhav, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_msb5fmnrh73qo069hebh6ks6uk